(HealthDay) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release.
Jun 11, 2012
0
0
The older we get, the less likely we are to hear well, as our inner ear sensory hair cells succumb to age or injury. Intriguingly, humans are one-upped by fish here. Similar hair cells in a fish sensory system that dots their ...
Jul 16, 2015
0
12
Tens of millions of Europeans suffer from a hearing impairment of some degree. They range from the one child in 1,000 who is born deaf, to the many whose hearing is declining as they grow older.
Sep 24, 2013
0
0
Hearing damage which isn't yet severe enough to be diagnosed as hearing loss is common in young adults who regularly attend loud music events, according to University of Manchester led research.
Jul 2, 2020
0
2
Immune system cells known as natural killer (NK) cells play an important protective role against hearing loss in mice infected with cytomegalovirus (CMV), according to a new study published in PLOS Pathogens.
Sep 29, 2017
0
8
A novel antibody-drug conjugate continues to demonstrate superior benefit for patients with HR+, HER2- metastatic breast cancer when compared to standard chemotherapy, according to a new study in The Lancet.
Aug 24, 2023
0
3
(Medical Xpress)—Researchers from the Department of Otolaryngology at the University of Melbourne and the Department of Biochemistry and Molecular Biology at Monash University have discovered how hearing loss in humans ...
Jun 11, 2013
0
0
People who have cancer might have the disease treated with several therapies, including chemotherapy and radiation. Radiation therapy, which more than half of all people with cancer receive as part of their treatment, uses ...
Jul 27, 2023
0
13
A team of researchers led by Dr. Michel Cayouette at the IRCM made an important discovery, published online yesterday by the scientific journal Developmental Cell, that could better explain some inherited forms of hearing ...
Oct 15, 2013
0
0
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone. In a nationwide analysis of nearly 20,000 patients whose cancer ...
Aug 6, 2020
0
0
